Cirrhosis is closely attributed to Varices in his research. Paul Calès combines Varices and Esophageal varices in his research. His research links Portal hypertension with Esophageal varices. Portal hypertension is closely attributed to Cirrhosis in his research. As part of his studies on Internal medicine, Paul Calès frequently links adjacent subjects like Procollagen peptidase. His Procollagen peptidase study frequently draws parallels with other fields, such as Internal medicine. His Gastroenterology study often links to related topics such as Ascites. Much of his study explores Ascites relationship to Gastroenterology. He undertakes interdisciplinary study in the fields of Chronic liver disease and Alcoholic liver disease through his works.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
Jérôme Boursier;Olaf Mueller;Matthieu Barret;Mariana Machado.
A novel panel of blood markers to assess the degree of liver fibrosis
Paul Calès;Frédéric Oberti;Sophie Michalak;Isabelle Hubert-Fouchard.
Sources of variability in histological scoring of chronic viral hepatitis.
Marie-Christine Rousselet;Sophie Michalak;Florence Dupré;Anne Croué.
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.
Thierry Poynard;Paul Calès;Linda Pasta;Gaetano Ideo.
The New England Journal of Medicine (1991)
Noninvasive diagnosis of hepatic fibrosis or cirrhosis
F Oberti;E Valsesia;C Pilette;MC Rousselet.
Determination of reliability criteria for liver stiffness evaluation by transient elastography.
Jérôme Boursier;Jean-Pierre Zarski;Victor de Ledinghen;Marie-Christine Rousselet.
Recombinant human α‐interferon in patients with chronic non‐A, non‐B hepatitis: A multicenter randomized controlled trial from France
Patrick Marcellin;Nathalie Boyer;Emile Giostra;Claude Degott.
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon;Pierre Nahon;Valérie Bourcier;Richard Layese;Etienne Audureau.
Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.
Christophe Cassinotto;Jérome Boursier;Victor de Lédinghen;Jérome Lebigot.
Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices.
Jean-Pierre Pascal;Paul Cales.
The New England Journal of Medicine (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: